| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |